Because TMP penetrates the blood-brain barrier, we sought to test the utility of ecDHFR tags for neurogenetic and behavioral research. Supporting previous studies in rats 16 , we found that TMP reaches a peak concentration in the mouse brain within 10 min after intraperitoneal (i.p.) injection and declines below detection threshold by 30 min after injection (see Online Methods). In cultured neurons, TMP acutely restored the levels and biological activity of various soluble and membrane DD-POIs localized to cytoplasm, neurotransmitter vesicles and nucleus ( Supplementary Fig. 1 and data not shown). We then fused ecDHFR to Cre recombinase (DD-Cre) (Supplementary Fig. 2 ), considering that this regulatory element can be used in a wide range of experimental systems. When introduced into cortical cultures with a lentivirus, DD-Cre was rapidly stabilized by the drug. Side-by-side comparison of DD-Cre and Cre-ER showed similar dependency on lentiviral titers of ligandinducible loxP recombination and background recombination levels ( Supplementary Fig. 3 ). Likewise, both Cre forms showed comparable background upon lentiviral expression in the cortex of Gt(ROSA)26Sor tm9(CAG-tdTomato)Hze (Rosa26 Ai9 tdTomato) reporter mice. However, DD-Cre activated the expression of the reporter in a larger number of neurons in response to i.p. drug injections, suggesting efficient recombination can be achieved by a transient DD-Cre stabilization in vivo ( Supplementary Fig. 4 ).
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To examine performance of DD-Cre throughout the forebrain, we generated transgenic mice expressing DD-Cre under the control of the excitatory neuron-specific Camk2a (CamKIIα) promoter. Two independent founder lines were bred with an Ai9 strain (Fig. 1a) , and the resulting offspring were analyzed after postnatal week 4, when CamKIIα promoter activity reaches steady-state levels ( Supplementary Fig. 5 ). We initially subjected DD-Cre/Ai9 mutants to one or seven sequential daily TMP injections (170 µg per gram of body weight) to test whether multiple exposures to the drug boost recombination efficiency. A single TMP injection was sufficient to drive recombination in one of the lines, producing robust reporter expression ( Fig. 1b and Supplementary Fig. 6 ). The densities of tdTomato-positive neurons varied in distinct brain regions, probably reflecting the pattern of transgenic DD-Cre expression rather than its non-uniform stabilization across different areas. Indeed, repetitive injections did not result in improvement of recombination rates, and >80% of cells with detectable DD-Cre mRNA became tdTomato-positive in all domains after a single TMP dose. With exception of the dentate gyrus (DG), where 17% of mature granule cells expressed the reporter in the absence of TMP, constitutive DD-Cre activity was sparse in the cortex and hippocampus (Fig. 1c,  Supplementary Fig. 6 acute manipulation of gene and protein function in the brain is essential for understanding the mechanisms of nervous system development, plasticity and information processing. here we describe a technique based on a destabilized cre recombinase (dd-cre) whose activity is controlled by the antibiotic trimethoprim (tmP). We show that dd-cre triggers rapid tmP-dependent recombination of loxP-flanked ('floxed') alleles in mouse neurons in vivo and validate the use of this system for neurobehavioral research.
Studies of brain development, neural circuits underlying behavior and synaptic plasticity benefit from approaches that enable rapid genetic modification of intact circuits in live animals. Two such approaches commonly used in mice rely on loxP recombination mediated by the tamoxifen-inducible Cre-ER 1-3 and expression of cDNA under the control of tetracycline-dependent elements tTA and rtTA 4 . However, these methods have drawbacks, including side effects associated with the binding of tamoxifen to native estrogen receptors 5, 6 and relatively slow kinetics of induction and repression 4, 7, 8 . Several elegant tools have been developed to manipulate neuronal activity in the brain using light, small molecules and peptides [9] [10] [11] [12] [13] . Most of these techniques take advantage of properties unique to specific proteins and cannot be applied to the regulation of other polypeptide species. Recently, a general method for direct pharmacological control of protein stability has emerged 14, 15 . This technology utilizes mutant destabilizing (DD) forms of human FKBP12 or bacterial dihydrofolate reductase (ecDHFR), which can be attached to virtually any protein of interest (POI). Newly synthesized DD-POIs containing the FKBP12 or ecDHFR tags are degraded through the proteosomal pathway, but their decay can be blocked with the ligands shield-1 and TMP, respectively 14, 15 . TMP-inducible protein stabilization is particularly attractive for in vivo applications because TMP can be easily delivered to laboratory animals, exhibits a high rate of diffusion in peripheral tissues and nervous system and does not have endogenous targets in mammals 14, 16 .
high Ai9 reporter sensitivity and excessive DD-Cre copy number, as other transgenic strains generated in our laboratory showed an enrichment of CamKIIα-driven transcripts in the DG 17 . The second DD-Cre founder line showed virtually no leakiness but displayed TMP-dependent recombination only in a small fraction of cells, perhaps owing to mosaicism. Although unsuitable for biochemical and behavioral studies, these low-expression DD-Cre (LE-DD-Cre) mice are useful for imaging projections and synaptic connectivity of isolated neurons (Supplementary Fig. 7) .
To define the DD-Cre pharmacokinetics in the brain, we calculated the densities of neurons tagged with tdTomato in cortices of DD-Cre/Ai9 mice that were treated with one dose of TMP at different concentrations (between 8 and 170 µg per gram of body weight). Under these conditions we observed a linear TMP dose-response (Fig. 1d,f) . We also analyzed the time course of reporter expression in mice injected with TMP (170 µg per gram of body weight). The yield of modified genomic DNA as assessed by PCR and the numbers of cells with detectable tdTomato fluorescence reached plateaus ~24 h and 48 h after drug administration, respectively (Fig. 1e,g ). This delay in tdTomato induction is not surprising given that it requires protein synthesis.
The Rosa26 locus has a relaxed chromatin structure that makes it easily accessible to Cre (this also probably contributes to the observed background), so we investigated whether DD-Cre is capable of recombining other DNA substrates. To this end, we injected adeno-associated viruses encoding a floxed GFP reporter (AAV2.5 DIO-GFP) into the cortices of DD-Cre mice. TMP potently triggered recombination in this case as well, with no apparent increase in the density of GFP-positive neurons after repetitive drug treatments (Fig. 1h,i and Supplementary Table 1 ). We also found that drug-mediated recombination with minimum background can be achieved by adjusting the viral titers (Supplementary Fig. 8) .
To evaluate the applicability of DD-Cre for behavioral studies, we generated a mouse strain carrying DD-Cre and a Creinducible form of tetanus toxin (TeNT), which inhibits neurotransmitter release by cleaving the vesicular SNARE protein Syb2 (also known as VAMP2) 18 (Rosa26 floxstop-TeNT , Fig. 2a) . We treated DDCre/TeNT mice and their control (DD-Cre-negative) littermates with TMP, and examined their brains by immunostaining for TeNT, Syb2 and the transcription factor Zif268, a product of an immediate early gene whose expression is induced by synaptic excitation. Drug-injected mice had decreased Zif268 and Syb2 immunoreactivity ( Fig. 2b-e) . Immunoblotting revealed that Syb2 cleavage begins ~6 h after drug administration, reflecting the acute induction of TeNT mediated by DD-Cre (Fig. 2f,g ). Electrophysiological recordings from brain slices confirmed a TMP-dependent loss of excitatory synaptic strength in DD-Cre/TeNT mice ( Fig. 2h and 
Supplementary Table 2).
We then asked how TMP-inducible synaptic silencing, residual DD-Cre activity and TMP itself affect information processing in the forebrain. To accomplish this, we examined vehicle-and npg drug-injected DD-Cre/TeNT mutants and their Cre-negative littermates using a battery of behavioral tests. No genotypic or drug-dependent changes were detected in locomotion and vision (Fig. 3a, Supplementary Fig. 9 and Supplementary Table 3) . However, administration of TMP to DD-Cre/TeNT mice abolished recognition and spatial memory, as evidenced by their lack of interest in novel objects, loss of preference for target quadrants in the Barnes maze probe test and higher frequency of errors during the reversal test. In contrast, these memory forms were intact in vehicle-injected DD-Cre/TeNT and TeNT as well as TMP-treated TeNT strains (Fig. 3b,c, Supplementary Fig. 9 and Supplementary  Table 3) . Notably, all four groups of mice had normal associative memory (data not shown). Hence, neither TMP alone nor constitutive DD-Cre activity in the brain of DD-Cre/TeNT mice affects the behavior in open field and memory acquisition and retrieval, whereas inducible blockade of neurotransmission interferes with specific cortical-and hippocampal-dependent tasks.
The rapid kinetics, wide dynamic range and lack of detectable TMP side effects make DD-Cre system an attractive tool for a broad spectrum of neurogenetic applications. The temporal control of DD-Cre in vivo is faster than Cre-ERT2, tTA and rtTA, which usually require repetitive exposure to the inducing drugs 3, 7, 8, 19, 20 . DD-Cre's strong TMP dose dependence also makes it an ideal tool for simultaneous perturbation and tagging of small populations of cells for the study of cell-autonomous mechanisms. Similar to other chemical-genetic methods, DD-Cre may exhibit constitutive background. Although our analyses indicate no behavioral consequences of such background in adult DD-Cre/TeNT mice and suggest that tight regulation can be attained at the cellular level in vitro and in vivo, promoter strength, developmental profile of DDCre expression and sensitivity of its downstream targets should be taken into consideration when designing new mouse strains. Viewed in a broader scope, our results provide a framework for future development of animal models carrying destabilized proteins in specific tissues and cell types. For example, attaching DD tags to transcription factors, membrane receptors and signaling molecules may enable wide control over different protein functions and facilitate research of cellular differentiation and metabolism. Furthermore, these tags can potentially be used in combination with other common elements such as FLP and tTA and rtTA (for dual pharmacological control). The performances of DD-POIs may be influenced by rates of decay, recruitment of stabilized ligandbound fusions to appropriate subcellular domains and interference of DD tags with protein function. Thus, new DD systems should always be validated in cultured cells before in vivo experiments. methods Methods and any associated references are available in the online version of the paper. online methods Lentivirus shuttle vectors and in vitro studies. Sequences encoding DD-YFP, DD-Cre, Cre-ERT2, Cherry-H2B, GFP and floxstop-GFP were subcloned into lentivirus shuttle vectors containing a synthetic neuronal synapsin promoter. KD + DD-Syb2 vector was composed of H1 promoter driving a short hairpin RNA specific for mouse Syb2 (GTGCAGCCAAGCTCAAGCG) followed by the synapsin promoter and DD-Syb2 rescue cDNA sequence containing noncoding mutations that disable RNA interference. Methods for preparation of neuronal cultures, lentivirus production and infection, immunostaining, immunoblotting and electrophysiology were described previously 17, 21 .
A mycoplasma-free human embryonic kidney (HEK293/ ATCC) cell line was used to produce recombinant lentiviruses. All other in vitro experiments were performed with primary neuronal cultures.
Mice. The constitutive CamKIIα:Cre driver line, the R26 Ai9 Cre reporter (Gt(ROSA)26Sor tm9(CAG-tdTomato)Hze ) and the R26 floxstop-TeNT allele (Gt(ROSA)26Sor tm2(GFP/tetX)Gld ) were previously characterized 18, 22, 23 . To generate CamKIIα:DD-Cre transgenic strains, a sequence encoding DD-Cre (Supplementary Fig. 2 ) was inserted downstream of the 8-kb (CamKIIα) promoter in a targeting vector that also included 5′ and 3′ introns flanking the cDNA and a 3′ SV40 polyA signal. The targeting construct was linearized and used for pronuclear microinjection at the TSRI Mouse Genetics Core. Positive founders were identified by PCR with the following primer pairs: GGCAATTGAGATCTACCATGATCTCTCTGATTGCCG and CGCCGCTAGCTAATCGCCATCTTCCAGCAG (1.3-kb product specific for DHFR-Cre); CTCCGTTTGCACTCAGGAGCAC and GCGCGGCGCGCCTCTCCTTTCCAGGATCTCAAAG (0.9-kb product specific for CamKIIα promoter and ecDHFR). Founders were then mated with mice carrying Ai9 or R26 floxstop-TeNT alleles (mixed C57/Bl6 and 129/sv background), and their offspring were genotyped and used for experiments.
Adult wild-type C57/Bl6 mice were used for TMP pharmacokinetic studies. All other experiments were performed with male and female mutant mice of mixed backgrounds (C57/Bl6 and 129/SV). Except for Supplementary Figure 5 , all imaging, biochemical and functional studies were performed with P30-P37 mice. P60 mice were used for behavioral analysis (Fig. 3  and Supplementary Fig. 9 ).
In vivo drug injection. Trimethoprim (Sigma, T7883) was reconstituted in DMSO at the saturating concentration of 100 mg/ml. This solution was prepared fresh for every experiment and diluted in 0.9% saline immediately before injections. Intra-peritoneal (i.p.) injections were carried out using a 29-g needle to deliver TMP doses of 8-170 µg per gram of body weight. Vehicle solution containing saline and DMSO was used as a control. TMP pharmacokinetics was examined in wild-type C57/BL6 mice using an in vitro bioassay based on inhibition of bacterial growth. TMP reached peaked concentrations in brain extracts of 1 µg/ml at 10 min following a single injection (50 µg/g). The maximum daily TMP doses did not exceed 170 µg/g to avoid potential distress and precipitation of the drug. Mutant animals were analyzed at various time-points after drug treatments, as indicated in figure legends. Tamoxifen was reconstituted in corn oil (10 mg/ml) and injected at 100 µg/g body weight.
In vivo virus injection. Concentrated lentiviruses were produced in house. AAV2.5 DIO-GFP was generated at the Salk vector core using a shuttle vector composed of 1.26 kb EF1α promoter and inverted GFP sequence flanked by two pairs of loxP sites. Viral titers were determined by PCR. Newborn pups were anesthetized on ice and injected with 0.5 µl of the viral stock using a glass micropipette (10 µm tip diameter). Pups were then warmed for 1-2 min under an incandescent lamp and returned to home cages until experiments.
Immunohistochemistry. Mice were anesthetized with isoflurane and perfused with 4% PFA. The brains were incubated overnight in 0.5% PFA, and sliced in PBS using a vibratome. The 90-µm thick brain sections were briefly boiled in 0.1 M citrate solution for antigen retrieval, and subsequently placed for 5 min into citrate buffer (40.5 ml of 0.1 M sodium citrate, 9.5 ml of 0.1 M citric acid (pH 6.0)). Sections were then washed in PBS, blocked for 3 h in 4% BSA, 2% horse serum and 0.5% Triton X-100 and incubated overnight with primary antibodies diluted in blocking solution, followed by washes in PBS and incubation with DAPI and/or corresponding fluorescence-labeled secondary antibodies.
Antibodies. Monoclonal anti-Syb2 (Cl69.1) and polyclonal antiSyt1 antibodies were a kind gift of T. Südhof. Anti-β-tubulin, anti-Zif268 and anti-SPO antibodies were purchased from Sigma (cat. no. T2200), Cell Signaling Technologies (cat. no. 4153S) and Synaptic Systems (cat. no. 102-002), respectively. All antibodies were used at 1:1,000 dilution for immunoblotting and immunohistochemistry.
In situ hybridization. Probes for DD-Cre and tdTomato transcripts were synthesized using the Roche RNA labeling kit, validated by electrophoresis and sequencing and tagged with either FITC or DIG. Brain sections were prepared as described above and acetylated in the buffer containing triethanolamine and acetic anhydride. Sections were then prehybridized at 65° C in buffer composed of 50% formamide, 5× saline-sodium-citrate, 5× Denhardt's solution, 250 µg/ml yeast tRNA, 500 µg/ml herring sperm DNA, 50 µg/ml heparin, 2.5 mM EDTA, 0.1% Tween-20 and 0.25% CHAPS followed by overnight incubation with heatdenatured probes diluted in the same buffer. Labeled sections were washed in 0.2× SSC, equilibrated in 100 mM Tris-HCl (pH 7.5) and 150 mM NaCl and blocked in 0.5% PerkinElmer Blocking Reagent in TN buffer. Sections were then washed in 0.05% Tween-20 followed by Tyramide amplification (PerkinElmer TSA Plus system), and sequential treatments with anti-FITC-POD and FITC-Tyramide. Upon quenching peroxidase activity with 3% hydrogen peroxide, sections were treated with anti-DIG-POD (1:500), washed and mounted for analysis.
Image acquisition and data analysis. Images were collected under the Nikon C2 confocal microscope using 10×, 20× and 60× oil-immersion objectives. Digital images were initially processed with the Nikon Elements software package. Digital manipulations were applied equally to all pixels. The densities of reporter-positive neurons were calculated automatically using Metamorph software. Three-dimensional reconstructions of GCs shown in Supplementary Figure 7 were performed with the Neurolucida package. npg PCR. Genomic DNA was isolated from the cortices of DD-Cre/TeNT mice at different time points after TMP injection and analyzed by PCR with the following primer pair specific for the recombined allele: CGTGCTGGTTATTGTGCTGTCTCATC and CCTCGGCGCGGGTCTTGTAGTTGCC.
Electrophysiology. Anesthetized mice were decapitated into oxygenated Ca 2+ -free artificial cerebrospinal fluid (ACSF) solution composed of 124 mM NaCl, 2 mM KCl, 1.25 mM KH 2 PO 4 , 2 mM MgSO 4 , 26 mM NaHCO 3 and 10 mM dextrose (pH 7.4). Brain sections (400 µm) were prepared using a vibratome. Slices were transferred to ACSF containing 2 mM Ca 2+ and allowed to recover for 1 h at 30° C before recordings. Excitatory field potentials were monitored from DG granule cells using a glass electrode filled with 2 M NaCl (~3 MΩ). Synaptic responses were elicited by an extracellular electrode (concentric bipolar electrode, FHC) placed near perforant path and recorded in the presence of 20 µm gabazine. Data were sampled with Multiclamp 700B amplifier and analyzed offline using Clampfit10 and Origin8 software packages.
Behavioral studies. Behavioral studies were conducted at the TSRI core facility according to protocols approved by the Institutional Animal Care and Use committee. Mice were injected once with either vehicle or TMP solution (170 µg per gram of body weight) 48 h before initiation of behavioral trials. All experiments were performed by an experimenter who was unaware of genotypes.
Locomotor activity. Locomotor activity was measured for 2 h in polycarbonate cages (42 × 22 × 20 cm) placed into frames (25.5 × 47 cm) mounted with two levels of photocell beams at 2 cm and 7 cm above the bottom of the cage (San Diego Instruments, San Diego, CA). These two sets of beams allow for the recording of both horizontal (locomotion) and vertical (rearing) behavior.
Vision. Vision was assessed in a stationary elevated platform surrounded by a drum with black-and-white-striped walls. Mice were placed on the platform to habituate for 1 min, then the drum was rotated at 2 r.p.m. in one direction for 1 min, stopped for 30 s then rotated in the other direction for 1 min. The total number of head tracks (15° movements at speed of drum) was recorded. In our hands, mice that have intact vision track 5-25 times, whereas blind mice do not track at all.
Novel-object test. The novel-object test assays recognition memory while leaving the spatial location of the objects intact. Mice were individually habituated to a 51 cm × 51 cm × 39 cm open field for 5 min. Mice were then tested with two objects placed in the field (Playmobil, Geobra Brandstatter GmbH & Co. KG, Zirndorf, Germany). The objects chosen (for example, unicorn, cow, boy and queen) were made of durable nontoxic plastic and are fixed to 10 cm × 7 cm × 0.5 cm square clear Plexiglas bases to prevent mice from moving the objects during testing 24 . For the familiarization trials, two different objects were placed in the open field, and an individual animal was allowed to explore for 5 min. After four familiarization trials (separated by 1 min in a holding cage), the mouse was tested in the object novelty recognition test in which a novel object replaced one of the familiar objects. All objects and the arena were thoroughly cleaned with 70% ethanol between trials to remove odors. Behavior was video recorded and then scored for contacts (touching with nose or nose pointing at object and within 0.5 cm of object). Habituation to the objects across the familiarization trials (decreased contacts) is an initial measure of learning and then renewed interest (increased contacts) in the new object indicates successful object memory.
The Barnes maze test. The Barnes maze test is a spatial learning and memory test originally developed in rats 25 but also adapted for mice 26 . It consists of an opaque Plexiglass disc 75 cm in diameter elevated 58 cm above the floor by a tripod. Twenty holes, 5 cm in diameter, are located 5 cm from the perimeter, and a black Plexiglass escape box (19 cm × 8 cm × 7 cm) is placed under one of the holes. Distinct spatial cues are located around the maze and are kept constant throughout the study.
Acquisition. On the first day of testing, a training session was performed, which consisted of placing the animals in the escape box for one minute. At the beginning of each session, mice were placed in the middle of the maze in a 10-cm-high cylindrical black start chamber. After 10 s the start chamber was removed, a buzzer (80 dB) and a light (400 lx) were turned on, and mice were set free to explore the maze. The session ended when mice entered the escape tunnel or after 3 min elapsed. When mice entered the escape tunnel, the buzzer was turned off and animals were allowed to remain in the dark for 1 min. If a mouse did not enter the tunnel by itself it was gently put in the escape box for 1 min. The tunnel was always located underneath the same hole (stable within the spatial environment), which was randomly determined for each mouse. Mice were tested once a day for 4 days for the acquisition portion of the study.
Probe test. For the fifth test (probe test), the escape tunnel was removed and mice were allowed to freely explore the maze for 3 min. The time spent in each quadrant was determined and the percent time spent in the target quadrant (the one originally containing the escape box) was compared with the average percent time in the other three quadrants. This is a direct test of spatial memory, as there is no potential for local cues to be used in the mouse's behavioral decision. Two weeks later the mice were tested for long-term memory with the escape box in the original position (retention test).
Reversal test. On the day after retention test, the escape tunnel was moved to a new location (90° from the original position) and the behavior of the mouse was recorded. This test allows for the examination of perseveration at the original location as well as the working memory strategies the mice adopt to locate the new tunnel location. Each session was videotaped and scored by an experimenter blinded to the mouse genotype. Measures recorded include the number of errors made per session and the latency to locate and enter the escape tunnel. Errors are defined as nose pokes and head deflections over any hole that did not have the tunnel beneath it.
Associative memory. Mice were allowed to explore the fear conditioning boxes for 3 min and were then presented with four 20-s periods of white noise, each paired with an electric foot shock (0.6 mA) during the last 2 sec (1-min inter-tone/shock intervals). Contextual memory testing consisted of one 3 min exposure to the training box (Med Associates SD) and was followed by cued memory testing 2 h later. Mice were introduced to an alternative box and presented with four 20-s periods of white noise at 1-min intervals. Freezing was determined in 0.75-s bouts and expressed as percent time in the context or of tone presentation. Contextual freezing was normalized by subtracting the freezing before the first white-noise presentations during conditioning. 
